News - BioPharm International

ADVERTISEMENT

News

Bristol-Myers Squibb and Five Prime Therapeutics Collaborate on Development of Immunomodulator

November 26, 2014

Opdivo and investigational agent FPA008 will be tested in combination for their efficacy in boosting antitumor immune response.

Merck Enters into Licensing Agreement with NewLink for Investigational Ebola Vaccine

November 25, 2014

Merck announced an agreement with NewLink Genetics to acquire exclusive rights to its experimental Ebola vaccine, rVSV-EBOV, for $50 million.

FDA Extends Review of Novartis' Investigational Compound for Multiple Myeloma

November 25, 2014

FDA will delay its decision regarding the new drug application for panobinostat.

AstraZeneca Expands Biologics Manufacturing in Maryland

November 25, 2014

The more than $200 million project will increase production capacity at the facility to support AstraZeneca?s maturing pipeline.

GSK Leads Big Pharma in Making Its Medicines Accessible

November 24, 2014

An index from the Access to Medicine Foundation ranks GSK as most effective in making products accessible.

IMS: Global Spending on Medicines to Rise 30% by 2018

November 24, 2014

Approximately 40% of total global growth will come from specialty medications, according to a new report from the IMS Institute for Healthcare Informatics.

Tufts’ New Figures on Drug-Development Costs Spark Debate

November 24, 2014

Tufts research suggests costs to launch a new drug have doubled since 2003, but some question conclusions.

Janssen Partners with Transposagen Biopharmaceuticals for CAR-T Therapies

November 24, 2014

The announcement calls attention to another partnership in the growing T-cell receptor engineering space.

FDA to Increase its Ties to China

November 24, 2014

Margaret Hamburg, FDA Commissioner, visited China recently to oversee efforts to strengthen inspection and regulatory reviews and to attend the Ninth International Summit of Heads of Medicines Regulatory Agencies Meeting

ADVERTISEMENT

ADVERTISEMENT

Click here